U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/NHLBI HIV/AIDS Program

NHLBI HIV/AIDS Program
                        
                                                Point of contact
            
                
            Shimian Zou, Ph.D.
                                        On this page
                        At a Glance
                                                                                                                    Why It's Important
                                                            Scientific Discovery Contributions
                                                            How It's Conducted
                                                            Current Team Members
                                                                                        Feature
                                                                                        Related Reading
        What is the goal of the NHLBI HIV/AIDS Program?
                        
            The NHLBI HIV/AIDS Program leads global research, training, and education programs on HIV-related heart, lung, blood, and sleep (HLBS) disorders, as well as blood-based therapies. Critical research discoveries in these areas will improve the survival and quality of life of people with HIV and may also lead to knowledge that benefits all people with heart, lung, blood, and sleep disorders.

These NHLBI Divisions work together on the NHLBI HIV/AIDS Program.

TheDivision of Cardiovascular Sciences (DCVS)focuses on understanding the higher risk ofcardiovascular diseasein people with HIV and testing new and existing cardiovascular treatments.
	TheDivision of Lung Diseases (DLD)addresses HIV-associated pulmonary infections, non-infectious complications such asCOPD,asthma,pulmonary hypertension, andsleep disorders.
	TheDivision of Blood Diseases and Resources (DBDR)focuses on HIV-associated blood abnormalities, hematopoietic cell and gene therapy for an HIV cure, and prevention of HIV spread through blood transfusion.
	TheCenter for Translation Research and Implementation Science (CTRIS)plans and supports research to find the best strategies for applying evidence-based interventions in clinical and public health settings, such as health centers, worksites, communities, and schools. This includes research on lowering barriers to implementing interventions for the prevention, control, and treatment of heart, lung, blood, and sleep disorders in people with HIV.
                AT A GLANCE
                                        The cross-NHLBI HIV/AIDS Program facilitates innovative research on HIV-related heart, lung, blood, and sleep disorders and the evolving challenges for people
          The MACS/WIHS Combined Cohort Study (MWCCS) aims to understand and lower the impact of health problems that affect people with HIV.
          The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) informs clinical approaches to prevent cardiovascular disease in people with HIV.
            Why is the NHLBI HIV/AIDS Program important?
    Huge progress in the treatment of HIV has led to higher survival rates and a dramatic evolution in understanding the disease. Trends over the past decades reveal that, overall, people are living longer with HIV. As a result, the challenges have now shifted from acquired immunodeficiency syndrome, or AIDS — the most advanced stage of the HIV infection — to other long-term diseases, such as coronary heart disease,chronic obstructive pulmonary disorder(COPD), and chronicanemia. Many studies have shown that people with HIV have a much higher risk of developing heart, lung, and blood conditions and that these conditions may develop earlier in people with HIV compared to the general population.********
    More Information
      
	-
		NHLBI HIV/AIDS Program
    Because people with HIV are living longer, new research is needed to better understand the long-term effects of long-term infection, inflammation, and use of antiretroviral medications. The NHLBI HIV/AIDS Program also supports research on the effects of HIV in children and young adults. It is important to include children in research because cardiovascular risk factors develop earlier in children with HIV, and children with HIV are also at risk of developingcardiomyopathy.
              How does the NHLBI HIV/AIDS Program contribute to scientific discoveries?
    The NHLBI HIV/AIDS Program has funded a wide range of HIV-related heart, lung, blood, and sleep disorders research, including the following:

Centers for AIDS Researchto provide expertise and resources for high-quality, multidisciplinary AIDS research
	Genetic Engineering Technologies for HIV Cure Researchto develop cell and gene therapies, including hematopoietic stem cell transplants, as well as nontraditional antiviral strategies to cure HIV-1, the most widespread type of HIV
	Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB-SIMPLe)to best deliver proven-effective prevention and treatment interventions for heart, lung, blood, and sleep diseases and disorders in people with HIV in World Bank designated low- and middle-income countries and Small Island Developing States.
	Implementation Research to Develop Interventions for People Living with HIV (PRECluDE)to support implementation research on proven-effective interventions for heart, lung, blood, and sleep diseases and conditions among people with HIV. These discoveries will fully implement guideline-based practices, late-stage T4 translation research, and implementation science strategies that address barriers to guideline-based interventions in community and clinical settings.
	Investigating HIV-Associated Lung Disease (INHALD)network to better understand the cellular and molecular events underlying HIV-associated lung diseases. While the study itself has ended, data and specimens can be requested for research purposeshere.
	Lung HIV Microbiome Project (LHMP)to test the lung microbiome in people who have and do not have HIV. People with HIV are at high risk for developingpneumoniaand have less lung function after pneumonia — an aftereffect not seen in people who do not have HIV. Data and specimens for this study can be requested throughBioLINCC.
	Martin Delaney Collaboratories for HIV Cure Researchto foster multidisciplinary collaborations between basic, applied, and clinical researchers studying HIV that stays in the body’s cells despite treatment (HIV persistence) and developing potential cures
	Multicenter AIDS Cohort Study (MACS)/Women’s Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS)to advance HIV science and lower the impact of long-term health conditions that affect people with HIV
	Pediatric HIV/AIDS Cohort Study (PHACS) to understand the safety of HIV treatment in children
	Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)to inform clinical approaches to prevent cardiovascular disease in people with HIVView funding information for the NHLBI HIV/AIDS Program.

The NHLBI encourages researchers to use existing NIH clinical/observational cohorts, biological specimens, databases (such asdbGaP), or imaging banks whenever possible for HIV-related heart, lung, blood, and sleep disorder research. Investigators interested in using data and stored samples from NHLBI studies can submit a request through the NHLBIBiologic Specimen and Data Repository Information Coordinating Center (BioLINCC). In addition, theMACS/WIHS Combined Cohort StudyData Analysis and Coordinating Center handles requests for data and biospecimens related to the study.

The following are HIV/AIDS research resources that the NIH Office of AIDS Research provides.

Strategic Plan for Trans-NIH Plan for HIV-Related Research
	NIH HIV/AIDS Early Career Investigator Resources
	NIH HIV/AIDS Online Resources
	NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding
              How is the NHLBI HIV/AIDS Program conducted?
    This cross-NHLBI program funds innovative research that responds to the evolving challenges of HIV. The NHLBI HIV/AIDS Team coordinates all HIV-related research in heart, lung, blood, and sleep, including translation research and implementation science. The NHLBI began holding working group meetings to identify research priorities in 2012. The Institute has since developed various initiatives to support research targeting HIV-related priorities.
    More Information
      
	-
		NHLBI HIV/AIDS Program
    The NHLBI identifies key HIV-related research priorities in the areas of heart, lung, blood, and sleep science in part by convening HIV/AIDS Working Groups. Prior Working Groups include:

The September 2019 Workshop on HIV-associated Comorbidities, Coinfections and Complications, led by the NHLBI and the NIH Office of AIDS Research (OAR) with support from 19 other NIH institutes, centers, and offices (ICOs). The workshop included five working groups focused on epidemiology and population science, disease origin and development, and basic science, clinical research, implementation science, and syndemics (disease interactions and social, cultural, environmental, political, and economical factors that influence or worsen diseases or conditions). The workshop also included a panel targeting international research.View the workshop summary.
	The December 2015 Working Group where members discussed topscientific prioritiesfor HIV/AIDS-related heart, lung, blood, and sleep research, including studies on epidemiology, disease processes, prevention, control, and treatment of HIV-related diseases and conditions.View the detailed recommendations from the 2015 meeting.
	The September 2012 Working Group, which focused on epidemiology, disease processes, prevention, and treatment of HIV-related heart, lung, and blood diseases, and the potential use of cell-based therapies to eliminate HIV.View the detailed recommendations from the 2012 meeting.Based on the recommendations of the HIV/AIDS Working Groups, the NHLBI has developed dedicated“HIV-related funding opportunity announcements (FOAs)”that highlight scientific opportunities in HIV-related heart, lung, blood, and sleep science.View funding information for NHLBI HIV/AIDS program research.
              Who are the current NHLBI HIV/AIDS team members?
    Contact information for NHLBI HIV/AIDS Program team members is available in the areas of heart, lung, blood, and sleep research; biostatistics; clinical research; translation research; implementation science; and grant management.
    More Information
      
	-
		NHLBI HIV/AIDS Program
    ****

**Shimian Zou, Ph.D.**NHLBI HIV/AIDS Coordinatorshimian.zou@nih.govmailto:

**DaRel Barksdale, MPH**NHLBI HIV/AIDS Scientific Program Managerdarel.barksdale@nih.govmailto:

***Cardiovascular Team***

**Gabriel Anaya, M.D.**Medical Officer/Program Director, Epidemiology Branch

MWCCS liaison

gabriel.anaya@nih.gov

****

**Patrice Desvigne-Nickens, M.D.**Medical Officer/Program Director, Heart Failure and Arrhythmias Branch

REPRIEVE liaison

desvignp@nhlbi.nih.govmailto:



**Ahmed A.K. Hasan, M.D., Ph.D.**Medical Officer/Program Director, Atherothrombosis & Coronary Artery Disease Branchhasana@nhlbi.nih.govmailto:

**Fassil Ketema, M.S.**Program Officer / Clinical Trials Specialist, Heart Failure and Arrhythmias Branchfassil.ketema@nih.govmailto:

***Lung and Sleep Team***

**Alfonso Alfini, Ph.D.**Program Director, Sleep Disorders Medicinealfonso.alfini@nih.govmailto:

**Emmanuel Mongodin, Ph.D.**Program Director, Lung Response to Pulmonary Infections, Microbiome and HIV/AIDSemmanuel.mongodin@nih.govmailto:

**Barry Schmetter**Clinical Trials Specialist, Division of Lung Diseasesschmetterb@nhlbi.nih.govmailto:

**Roy Sutliff, Ph.D.**Program Director, Vascular Biology & Pulmonary Hypertensionroy.sutliff@nih.govmailto:



***Blood Team***

**Nahed El Kassar, M.D., Ph.D.**Medical/Program Officer, Blood Epidemiology and Clinical Therapeutics Branchnahed.elkassar@nih.govmailto:

**Benyam Hailu, M.D., MPH**Medical/Program Officer, Blood Epidemiology and Clinical Therapeutics Branchglynnsa@nhlbi.nih.govmailto:



***Translation Research and Implementation Science Team***

**Maliha Ilias, Ph.D.**Program Director, Health Inequities & Global Health Branchmaliha.ilias@nih.gov

**Mary Masterson, Ph.D.**Program Director, Implementation Science Branchmary.masterson@nih.gov

**Keith Mintzer, Ph.D.**Program Director, Implementation Science Branchkeith.mintzer@nih.gov



***Division of Extramural Research Activities Team***

**Tony L. Creazzo, Ph.D.**Scientific Review Officercreazzotl@nhlbi.nih.gov:mailto:

**John Diggs**Supervisory Team Leader, Office of Grants Managementjohn.diggs@nih.gov:

**Fatima Kamara**Grants Management Specialistfatima.kamara@nih.govmailto:

**Manoj Valiyaveettil, Ph.D.**Scientific Review Officermanoj.valiyaveettil@nih.gov:

**Lynn Rundhaugen**Grants Management Specialistlynn.rundhaugen@nih.govmailto:

******

***Financial Management Team***

**Lina Allen**NHLBI Budget Officerallenli@nhlbi.nih.govmailto:

**Larry Martin**Budget Analystlarry.martin@nih.gov:

**William Stryker**Senior Budget Analystwilliam.stryker@nih.gov:
                FEATURE
                                        blood transfusion old man
                        NHLBI HIV/AIDS Program Addresses Increasing Burden of Chronic Disease for HIV-Infected Individuals
                            Tremendous progress in the treatment of HIV has led to increased survival and a dramatic evolution of the disease’s course in patients.
                                                        
            Read more about the NHLBI HIV/AIDS Program.
                            Related Scientific Focus Areas
                                    Blood Disorders and Blood Safety
              Heart and Vascular Diseases
              Lung Diseases
              Sleep Science and Sleep Disorders
                                                                                                                                                                Related Health Topics
                                    What Is Coronary Heart Disease?
              What Is COPD?
              What Is Anemia? Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs